REFERENCES
- Shen D. D., Azarnoff D. L. Clinical pharmacokinetics of methotrexate. Clin. Pharmacokinet. 1978; 3: 1–13
- Bertino J. R. The mechanism of action of the folate antagonists in man. Cancer Res. 1963; 23: 1286–1306
- Hersh E. M., Vernon G., Edward S. H., Freireich J. E. Hepatotoxic effects of methotrexate. Cancer 1966; 19: 600–606
- Bleyer W. A. The clinical pharmacology of methotrexate. Cancer 1978; 41: 36–51
- Boetcher D. A., Leonard E. J. Abnormal monocyte chemotactic response in cancer patients. J. Natl. Cancer Inst. 1974; 52: 1091–1099
- Bock N. S., Cameron R. B., Kragel P., Mule J., Rosenberg S. A. Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice. Cancer Res. 1991; 51: 2649–2654
- Horiguchi J., Sariban E., Kufe D. Transcriptional and posttranscriptional regulation of CSF-1 gene expression in human monocytes. Mol. Cell. Biol. 1988; 8: 3951
- Wong G. G., Witek J. S., Temple P. A. Human GM-CSF: Molecular cloning of the complementary DAN and purification of the natural and recombinant protein. Science 1985; 228: 810–815
- Brandt S. J., Peters W. P., Atwater S. K., Kurtzberg J., Borowitz M. J., Jones R. B. Effect of recombinant human macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N. Engl. J. Med. 1988; 318: 869–876
- Clark S. C., Kamen R. The human hematopoietic colony stimulating factors. Science 1987; 236: 1229–1237
- Das S. K., Stanley E. R. Structure-function studies of a colony stimulating factor (CSF-1). J. Biol. Chem. 1982; 257: 13679–13684
- Thomassen M. J., Barna B. P., Wiedemann H. P., Ahmad M. Modulation of human alveolar macrophages tumoricidal activity by recombinant macrophages colony stimulating factor. J. Biol. Resp. Modifiers 1990; 9: 87–91
- Hume D. A., Donahue R. E., Fidler I. J. The therapeutic effect of human recombinant macrophage colony stimulating factor in experimental murine metastatic melanoma. Lymphokine Res. 1989; 8: 69–77
- D'Souza M. J. Controlled release of cyclosporine from microspheres. Drug Dev. Ind. Pharm. 1988; 14: 1351
- Gupta P. K., Hung C. T. Albumin microspheres II: applications in drug delivery. J. Microencapsulation 1989; 6: 463–472
- Pourfarzib R., D'Souza M. J. Preparation of albumin microspheres containing macrophage colony stimulating factor. Pharm. Res. 1992; 9: S–68
- Pourfarzib R., Gajjar D., Riadi I., Oliver J., D'Souza M. J. Enzyme linked immunosorbent assay for detection of human tumor necrosis factor alpha. Pharm. Res. 1993; 10: S-1–400
- Pourfarzib R., Gajjar D., Riadi I., Oliver J., D'Souza M. J. Enzyme linked immunosorbent assay for detection of human interleukin-1 beta. Pharm. Res. 1993; 10: S-1–400
- Sampson-Johannes A., Carlino J. A. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. J. Immunol. 1988; 141: 3680–3686
- Yamada H., Iwase S., Mohri M., Kufe D. Involvement of a nuclear factor-kB-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor. Blood 1991; 78: 1988–1995
- Racoosin E. L., Swanson J. A. Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J. Exp. Med. 1989; 170: 1635
- Tabata Y., Ikada Y. Drug delivery systems for antitumor activation of macrophages. Ther. Drug Carrier Sys. 1990; 7: 121–148
- DeSouza P., Eshima D., D'Souza M. J. In-vivo uptake studies of polylactic co-glycolic acid microspheres in normal and arthritic rats after i.p. administration. Pharm. Res. 1990; 7: S–39
- DeSouza P., Eshima D., D'Souza M. J. In-vivo uptake studies of amino modified polystyrene latex microspheres in normal and arthritic rats after i.p. administration. Pharm. Res. 1990; 7: S–174
- D'Souza M. J., Uraizee S., Eshima D. In-vitro uptake of radiolabeled tyrosine-PLGA microspheres by the macrophages. Pharm. Res. 1991; 8: S–262
- D'Souza M. J., Uraizee S., Eshima D. In-vivo uptake of Tc-99m labeled tyrosine-PLGA microspheres in the blood after i.p. administration. Pharm. Res. 1991; 8: S–262
- Marcus C. S., Kuperus J. H., Butler J. A., Henneman P. L., Salk R. D., Chen B. Y., Vivian M. R. P., Yamanaka L. M. Phagocytic labelling of leukocytes with 99m Tc-albumin colloid for nuclear imaging. Nucl. Med. Biol. 1988; 15: 673–682
- Saha G. B., Feiglin D. H. I., O'Donnell J. K., Go R. T., Karam P. M., Macintyre W. Experience with technetium-99m albumin colloid kit for reticuloendothelial system imaging. Radiopharmacy 1896; 14: 149–151
- Taplin G. V., Johnson D. E., Dore E. K. Lung photoscans with macroaggregates of human serum albumin: Experimental basis and clinical trials. Health Phys. 1964; 10: 1219–1227
- Tabata Y., Ikada Y. Synthesis of gelatin microspheres containing interferon. Pharm. Res. 1989; 6: 422
- Dinarello C. A. Interleukin-1. Rev. Infect. Dis. 1984; 6: 51–95
- Freimann J. H., Markowitz A. B. Cytokines and chemotherapy: A new approach to therapy for solid tumors. Cancer Bull. 1991; 43: 224–232